The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Established in 1998, Union Biometrica is the pioneer in the development, manufacture, distribution and service of high throughput systems for the screening of "large" (10-1500 micron) particles These systems can analyze sort and dispense objects that are too large or too fragile for traditional flow cytometers. Typical samples include: - Delicate large cells / cell clusters such as adipocytes, embryoid bodies, pancreatic islets, duct cells and hepatocytes - Viable small multi-cellular model organisms like C.elegans, D. melanogaster and D. rerio - Beads (cells growing in or on beads, bead-based libraries) - Seeds (Arabidopsis, tobacco), pollen and certain types of fungi (Aspergillus)

Founded in 1980, Unigene is a publicly traded biopharmaceutical company with corporate offices, an R&D facility and a state-of-the-art recombinant manufacturing facility in New Jersey. There broad experience in molecular biology, protein chemistry, immunology and formulation development combined with there entrepreneurial spirit and innovation have led to the development of proprietary technologies, protected by a strong patent portfolio, enabling the commercialization of peptide drugs.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Genomatica develops biobased process technologies that enable a better way to produce widely-used chemicals, from alternative feedstocks, with better economics, sustainability, and performance. Genomatica has earned widespread acclaim for its technology; has commercialized processes for the chemical butanediol (for biodegradable plastics and apparel) and for butylene glycol (cosmetics and personal care), and is working on bio-nylon. Awards include the Kirkpatrick Award, for “the most noteworthy chemical engineering technology commercialized in the world” and the ICIS Innovation Award for its Brontide(TM) butylene glycol.

Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications. The company's product development portfolio includes MultiStem, a stem cell product, that is being developed as a treatment for multiple disease indications, is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, Athersys develops pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy, or other forms of excessive daytime sleepiness.

Symrise GmbH & Co. KG develops and produces flavors, fragrances, cosmetic ingredients and aroma chemicals. It supplies cosmetic raw materials and active ingredients to the international fragrance, cosmetics and food industry. It's core competencies are extraction and distillation-separation techniques used to isolate natural flavor components. With its new ayurveda Extrapone product range, it offers components from traditional ayurvedic plants and herbs such as sandalwood, lotus flower, cinnamon, ginger and neem. Founded in 2003, the company is headquartered in Holzminden, Germany.

UniCrop Oy develops sprouting technology for the production of therapeutic proteins. It develops prouting technology for the production of therapeutic proteins. It uses molecular biology technologies to develop new uses for plants. The company was founded by Kimmo Koivu and Viktor Kuvshinov in 1998 and is located in Helsinki, Finland.

Diamidex SAS provides research and development services in biotechnology. The company was founded by Sam Dukan in June 2019 and is headquartered in Marseille, France.

Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Oplon BV develops antimicrobial coating technology for packaging, pads and devices. It offers protective products, coatings and processes based on a novel polymer compound, which prevent the colonization of microbes by creating a protective physical shield on surfaces. The firm’s products are used by beverages, fresh meat and dairy markets. The company was founded in 2006 by Shmuel Bukshpan and Uriel Halavee and is headquartered in Delft, the Netherlands.

Icon Genetics GmbH develops biopharmaceuticals and protein products using plants. Its product candidates, engineered organisms, and technology platforms for plant biotechnology, and plant-based production. The firm develops generation production platforms and product prototypes for pharmaceutical, agricultural, animal health, and chemical biotech markets. The company was founded by Yuri Gleba, Newell Bascomb, and Hans-Ulrich Koop in 2000 and is headquartered in Halle, Germany.

The American Red Cross (ARC), also known as the American National Red Cross, is a humanitarian organization that provides emergency assistance, disaster relief, and education inside the United States. It is the designated U.S. affiliate of the International Federation of Red Cross and Red Crescent Societies. It is the largest single supplier of blood and blood products in the United States, collecting and processing approximately 40 percent of the blood supply and distributing it to about 2,600 hospitals and transfusion centers nationwide. The organization researches and tests to protect the safety of the blood supply. It was among the first to develop and implement testing for many infectious diseases including, HIV, hepatitis B and C viruses, West Nile virus, and Chagas disease. The ARC operates the nationwide hemovigilance program to examine donor and patient adverse reactions. Data from the program is used to enhance blood product quality and safety The ARC serves on key committees of AABB and other blood-related organizations, and works closely with the U.S. Food and Drug Administration (FDA). The American Red Cross was established in 1881 and is headquartered in Washington, District of Columbia with 39 immunohematology reference laboratories nationwide.